Proteomic profiling of end-stage COVID-19 lung biopsies

Table 1 Overview of the supporting patient information

Case ID	Group	Age (years)	Sex	Cause of death	First positive SARS-CoV-2 PCR (days)	PM interval (hours)	Antibiotic therapy	Oxygen therapy	ICU
P1	COVID-19	80	Female	Pneumonia	7	46	Yes	Yes	No
P2	COVID-19	81	Female	Pneumonia	11	23	No	Yes	No
P3	COVID-19	80	Male	Pneumonia	6	7	Yes	Yes	No
P4	COVID-19	54	Male	DAD + pneumonia	23	14	Yes	Yes	Yes
P5	COVID-19	65	Male	DAD	34	57	Yes	Yes	Yes
P6	COVID-19	79	Female	DAD	2	12	No	Yes	Yes
HP1	Control	58	Male	Multiorgan failure	Neg	48	Yes	Yes	No
HP2	Control	61	Male	Ruptured aortic aneurysm	Neg	61	No	Yes	No
HP3	Control	82	Male	Myocardial infarction	Neg	39	Yes	Yes	Yes
HP4	Control	82	Female	Myocardial infarction	Neg	102	No	No	No
HP5	Control	74	Male	Metastatic cancer	Neg	28	No	No	No
HP6	Control	82	Male	Pulmonary embolism	Neg	22	Yes	Yes	Yes

First positive SARS-CoV-2 PCR represents the time between PCR test and death. Post-mortem interval (PM) are the hours after death until autopsy/tissue collection. DAD diffuse alveolar damage, ARDS acute respiratory distress syndrome, ICU intensive care unit, PCR Polymerase chain reaction.

ISSN: 1559-0275